Member login

Temel Göstergeler


Turkish Pharmaceutical Market

Turkish Pharmaceutical Market (ex-factory prices)

The Turkish pharmaceutical market reached 33,0 billion Turkish Liras (TL) in the last 12 months as of March 2019. Unit sales reached 2,3 billion units.

Source: IQVIA, IEIS

Generic vs. Originator Drugs

Source: IQVIA,IEIS

Source: IQVIA,IEIS

Market Share of Generic vs Originator Drugs

Source: IQVIA,IEIS

Import-Local Products

Source: IQVIA, IEIS

Source: IQVIA, IEIS

Market Share - Local vs. Imports

Source: IQVIA, IEIS

Pharmaceutical Consumption by Therapeutic Class

Pharmaceutical Consumption in Value Terms by Therapeutical Class

Oncology represented the largest proportion by value, accounting for 12,8% of the total market. 

Source: IQVIA, IEIS

Pharmaceutical Consumption in Volume Terms by Therapeutical Class

Antibiotics and anti-rheumatism products represented the largest proportion by volume , accounting for 11,1% of the total market.

 

Source: IQVIA, IEIS

Biotechnological Products

Biotechnological products constituted 17,5% of prescription products with 5,7billion TL and 28,4 million units in the last 12 months as of March 2019. The reference biotechnological pharmaceutical market grew by 5,0% to total 5,4 billion TL. Biosimilar drugs market increased by 21,5% and reached 342 million TL

Source: IQVIA, IEIS

Source: IQVIA, IEIS

Foreign Trade

Pharmaceutical exports reached $1173 million in the last 12 months as of March 2019.

Source:TurkStat, IEIS